Killer to cure: Expression and production costs calculation of tobacco plant‐made cancer‐immune checkpoint inhibitors

Immune checkpoint inhibitors (ICIs) have achieved huge clinical success. However, many still have limited response rates, and are prohibitively costly. There is a need for effective and affordable ICIs, as well as local manufacturing capacity to improve accessibility, especially to low‐to‐middle inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ridgley, Laura A., Falci Finardi, Nicole, Gengenbach, Benjamin B., Opdensteinen, Patrick, Croxford, Zack, Ma, Julian K.‐C., Bodman‐Smith, Mark, Buyel, Johannes F., Teh, Audrey Y.‐H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214761/
https://www.ncbi.nlm.nih.gov/pubmed/36811226
http://dx.doi.org/10.1111/pbi.14034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214761/
https://www.ncbi.nlm.nih.gov/pubmed/36811226
http://dx.doi.org/10.1111/pbi.14034

Ejemplares similares